Company Announcements Nature reported in May that antibody supplier Santa Cruz Biotechnology had agreed to pay $3.5 million for the violation of the US Animal Welfare Act. The settlement also cancels the company’s license to sell, buy or import animals and its registration to operate as an animal research facility. DefiniGEN, a provider of stem […]
Company Announcements Olink announced reorganization, effective April 1. It now operates as two separate companies: Olink Proteomics, which offers the Proseek Multiplex product line, and Olink Bioscience, which is focused on developing and commercializing additional technologies. STEMCELL Technologies signed an exclusive licensing agreement with the Austrian Academy of Sciences’ Institute of Molecular Biotechnology for the […]
Company Announcements Epigenetic tools firm Cambridge Epigenetix closed a $21 million Series B financing in March, led by Google Ventures, and appointed Dr. Geoff Smith as CEO. Most recently, he served as site lead and vice president of Product Development at Illumina. Genovis announced a strategic cooperation agreement with CRO Alphalyse in which they will […]
Company Announcements SomaLogic announced collaborative projects with the University of Oxford to discover and characterize protein biomarkers. SomaLogic announced in March the receipt of up to $60.5 million in debt and equity financing from Visium Healthcare Partners. In February, Gen9 and SynbiCITE, a UK-based Innovation and Knowledge Centre, partnered to provide SynbiCITE access to the […]
Company Announcements SomaLogic established in December 2015 its first continental European SOMAscan Assay Site at VU University Medical Center Amsterdam. Mimetas received $1.6 million in industry funding to develop an organ-on-a-chip model for neurotoxicity. Mimetas will lead a consortium that includes the Institute for Risk Assessment Sciences and Cellular Dynamics. PerkinElmer and EpiCypher collaborated to […]
Company Announcements Corning announced in November 2015 that, as of January 1, it is distributing BioCision’s cell cryopreservation products. In November 2015, Baylor Miraca Genetics Laboratories licensed Oxford Gene Technology’s SNP array probe technology as an alternative to restriction enzyme–based approaches. Oxford Gene Tecnhnology announced that fiscal 2015 sales for the period ending September 30, […]
Company Announcements Israel-based Biological Industries launched a US subsidiary in October. BioCision announced a collaboration with the University of California, San Francisco Transplantation Research Laboratory of Dr. Qizhi Tang to advance cell therapy for organ transplantation and diabetes. In November, Desktop Genetics signed a partnership agreement with Transcriptic combining their respective CRISPR/Cas9 design software and […]
Company Announcements Horizon Discovery in October signed an in-licensing and option agreement with Servier for novel kinase inhibitors. Horizon will use its platform to identify the populations of cancer patients most likely to respond to the in-licensed compounds. BIOKÉ signed an exclusive agreement to distribute Horizon Discovery’s HDx Reference Standards in the Netherlands. For the […]
Company Announcements In September, Abcam announced that CFO Jeff Iliffe will resign within 12 months. Mara Glickman Aspinall has replaced him on the Board. She was formerly president and CEO of Ventana Medical Systems. Desktop Genetics, maker of the DESKGEN genome editing software, raised £1.37 million ($2.15 million). ArcherDX announced a partnership with BioChain to […]
Irvine, CA 10/26/15—The Orange County Business Journal reported that MP Biomedicals has been sold to Chinese chemical firm Valiant, a supplier of liquid crystal materials, pharmaceutical intermediates and photoelectronic chemicals, for around $134 million. MP Biomedicals is a provider of life science and diagnostic lab products, including life science consumables and lab chemicals. MP Chemicals […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
